| Any fracture: calcium alone | No clear reduction in the risk of any fracture was found with calcium alone compared with placebo or no supplement.RR 0.91 (95% CI 0.81–1.01); absolute difference −1.0 percentage points (−2.1…+0.1). | 3/4 ModeratePrecision of the estimate: The CI allows a small benefit and no effect. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: No separate downgrade is required for the specified contrast. | 1111 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗ | Adults, predominantly living at home, 9067 in 11 RCTs | - Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
|
|---|
| Hip fractures: calcium alone | The effect of calcium alone on hip fracture risk remains very uncertain.RR 1.63 (0.86–3.03), absolute difference +1.0 percentage points (−0.2…+3.2). | 1/4 Very lowPrecision of the estimate: The interval allows benefit and a substantial increase in risk. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Limitations of individual RCTs. | 66 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗ | Adults, predominantly living at home, 6703 in 6 RCTs | - Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
|
|---|
| Nonvertebral fractures: calcium alone | In the calcium-alone analysis, the estimate of nonvertebral fracture risk allowed both a decrease and an increase compared with control.RR 0.95 (0.79–1.14). | 3/4 ModeratePrecision of the estimate: The CI allows effects in either direction. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: No separate downgrade is required for the specified contrast. | 44 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗ | Adults, predominantly living at home, 3204 in 4 RCTs | - Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
|
|---|
| Vertebral fractures: calcium alone | In the calcium-alone analysis, the estimate of vertebral fracture risk allowed both a decrease and an increase compared with control.RR 0.82 (0.65–1.04). | 3/4 ModeratePrecision of the estimate: The CI includes no effect and possible benefit. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: No separate downgrade is required for the specified contrast. | 1010 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗ | Adults, predominantly living at home, 6576 in 10 RCTs | - Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
|
|---|
| At least one fall: calcium alone | No clear reduction in the probability of at least one fall was found with calcium alone compared with placebo or no supplement.RR 0.91 (0.78–1.06). | 3/4 ModeratePrecision of the estimate: Limited precision for the effect on risk. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: No separate downgrade is required for the specified contrast. | 22 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗ | Adults, predominantly living at home, 2966 in 2 RCTs | - Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
|
|---|
| Rate of falls: calcium alone | No clear reduction in the rate of falls was found with calcium alone compared with placebo or no supplement.Rate ratio 1.02 (0.96–1.09). | 3/4 ModeratePrecision of the estimate: No separate downgrade is required for the stated wording. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Two studies, including limitations in measuring recurrent events. | 22 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗ | Adults, predominantly living at home, 1794 in 2 RCTs | - Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
|
|---|
| Total bone mineral content in children and adolescents | In healthy children and adolescents, a review found a small increase in total bone mineral content compared with control. This outcome did not determine the effect on future fractures.SMD 0.14 (95% CI 0.01–0.27). | 2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed. | 99 trials in the reviewCalcium supplementation for improving bone mineral density in children ↗ | healthy children and adolescents, review of 19 RCTs, 2859 participants | - Calcium supplementation for improving bone mineral density in children ↗
|
|---|
| Femoral neck and lumbar spine bone density in children and adolescents | In healthy children and adolescents, no clear advantage of calcium over control was found for femoral neck or lumbar spine bone density.Femoral neck: SMD 0.07 (95% CI −0.05…0.19), 10 RCTs/1073 participants; lumbar spine: 0.08 (−0.04…0.20), 11 RCTs/1164 participants. | 2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed. | 11 review of studiesCalcium supplementation for improving bone mineral density in children ↗ | healthy children and adolescents in the RCTs in the review | - Calcium supplementation for improving bone mineral density in children ↗
|
|---|
| Nonvertebral fractures: calcium with vitamin D | In the overall analysis, calcium with vitamin D reduced nonvertebral fracture risk compared with control. After one influential trial was excluded, the reduction became uncertain.RR 0.87 (0.78–0.96); after excluding an influential RCT, 0.90 (0.78–1.05). | 2/4 LowPrecision of the estimate: Uncertainty about a small effect for an individual outcome. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: The result is limited by the original RCTs and the sensitivity of individual outcomes to an influential trial. | 77 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗ | Adults, predominantly living at home, 10324 in 7 RCTs | - Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
|
|---|
| Vertebral fractures: calcium with vitamin D | The estimate of vertebral fracture risk with calcium and vitamin D allowed both a decrease and an increase compared with control.RR 0.90 (0.74–1.09). | 2/4 LowPrecision of the estimate: Uncertainty about a small effect for an individual outcome. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: The result is limited by the original RCTs and the sensitivity of individual outcomes to an influential trial. | 44 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗ | Adults, predominantly living at home, 42185 in 4 RCTs | - Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
|
|---|
| At least one fall: calcium with vitamin D | A reduction in the probability of at least one fall with calcium and vitamin D compared with control remains uncertain.RR 0.92 (0.84–1.00). | 2/4 LowPrecision of the estimate: Uncertainty about a small effect for an individual outcome. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: The result is limited by the original RCTs and the sensitivity of individual outcomes to an influential trial. | 1010 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗ | Adults, predominantly living at home, 11068 in 10 RCTs | - Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
|
|---|
| Rate of falls: calcium with vitamin D | No clear difference in the rate of falls was found between calcium combined with vitamin D and control.Rate ratio 0.95 (0.88–1.03). | 2/4 LowPrecision of the estimate: Uncertainty about a small effect for an individual outcome. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: The result is limited by the original RCTs and the sensitivity of individual outcomes to an influential trial. | 44 trials in the reviewCalcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗ | Adults, predominantly living at home, 7532 in 4 RCTs | - Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis ↗
|
|---|
| Overall severity of premenstrual symptoms | Over three menstrual cycles, calcium carbonate reduced overall premenstrual symptoms in women with PMS more than placebo.Reduction in symptom severity from baseline by the third cycle: 48% with calcium versus 30% with placebo. | 2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed. | 11 trialCalcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms ↗ | 497 women with PMS randomized, 466 in the efficacy analysis | - Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms ↗
|
|---|
| Pain in primary dysmenorrhea: calcium alone | The adjusted estimate of menstrual pain was lower with calcium than with placebo; the analysis of pain changes over time between groups leaves the effect uncertain.−1.6 cm (95% CI −2.6…−0.6). Group × time interaction not significant. | 1/4 Very lowPrecision of the estimate: Small groups. The pain difference depends on the analysis, or the CI allows substantially different effects. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: One small RCT, multiple comparisons, and disagreement between the longitudinal test and the pairwise pain result. | 11 trialEffects of Calcium-Vitamin D and Calcium-Alone on Pain Intensity and Menstrual Blood Loss in Women with Primary Dysmenorrhea: A Randomized Controlled Trial ↗ | 85 female students with moderate or severe primary dysmenorrhea, three groups | - Effects of Calcium-Vitamin D and Calcium-Alone on Pain Intensity and Menstrual Blood Loss in Women with Primary Dysmenorrhea: A Randomized Controlled Trial ↗
|
|---|
| Pain in primary dysmenorrhea: calcium with vitamin D3 | No clear reduction in menstrual pain was found with calcium combined with vitamin D3 compared with placebo.−0.7 cm (95% CI −1.6…+0.3). | 1/4 Very lowPrecision of the estimate: Small groups. The pain difference depends on the analysis, or the CI allows substantially different effects. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: One small RCT, multiple comparisons, and disagreement between the longitudinal test and the pairwise pain result. | 11 trialEffects of Calcium-Vitamin D and Calcium-Alone on Pain Intensity and Menstrual Blood Loss in Women with Primary Dysmenorrhea: A Randomized Controlled Trial ↗ | 85 female students with moderate or severe primary dysmenorrhea, three groups | - Effects of Calcium-Vitamin D and Calcium-Alone on Pain Intensity and Menstrual Blood Loss in Women with Primary Dysmenorrhea: A Randomized Controlled Trial ↗
|
|---|
| Menstrual blood loss: calcium alone | The pictorial-scale estimate of menstrual blood loss allowed both a decrease and an increase with calcium alone compared with placebo.−0.4 points (95% CI −17.4…16.4). | 1/4 Very lowPrecision of the estimate: Small groups. The pain difference depends on the analysis, or the CI allows substantially different effects. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: One small RCT, multiple comparisons, and disagreement between the longitudinal test and the pairwise pain result. | 11 trialEffects of Calcium-Vitamin D and Calcium-Alone on Pain Intensity and Menstrual Blood Loss in Women with Primary Dysmenorrhea: A Randomized Controlled Trial ↗ | 85 female students with moderate or severe primary dysmenorrhea, three groups | - Effects of Calcium-Vitamin D and Calcium-Alone on Pain Intensity and Menstrual Blood Loss in Women with Primary Dysmenorrhea: A Randomized Controlled Trial ↗
|
|---|
| Menstrual blood loss: calcium with vitamin D3 | The pictorial-scale estimate of menstrual blood loss allowed both a decrease and an increase with calcium and vitamin D3 compared with placebo.−4.7 points (95% CI −21.9…12.4). | 1/4 Very lowPrecision of the estimate: Small groups. The pain difference depends on the analysis, or the CI allows substantially different effects. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: One small RCT, multiple comparisons, and disagreement between the longitudinal test and the pairwise pain result. | 11 trialEffects of Calcium-Vitamin D and Calcium-Alone on Pain Intensity and Menstrual Blood Loss in Women with Primary Dysmenorrhea: A Randomized Controlled Trial ↗ | 85 female students with moderate or severe primary dysmenorrhea, three groups | - Effects of Calcium-Vitamin D and Calcium-Alone on Pain Intensity and Menstrual Blood Loss in Women with Primary Dysmenorrhea: A Randomized Controlled Trial ↗
|
|---|
| Cramps in men aged 40 and over | At the two-year visit, cramps during the preceding six months were reported by 47% of men on placebo, 43% on 600 mg, and 51% on 1200 mg of calcium daily. No clear difference between groups was found (p=0.58).47% placebo, 43% with 600 mg, 51% with 1200 mg, p=0.58. | 2/4 LowPrecision of the estimate: No CI for the contrast is reported. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Secondary outcome, cramps assessed by questionnaire. | 11 trialRandomized Controlled Trial of Calcium Supplementation in Healthy, Nonosteoporotic, Older Men ↗ | 323 healthy men aged 40 and over without osteoporosis, 107 on placebo, 108 in each calcium group | - Randomized Controlled Trial of Calcium Supplementation in Healthy, Nonosteoporotic, Older Men ↗
|
|---|
| Handgrip strength in men aged 40 and over | Over two years in healthy men aged 40 and over without osteoporosis, no clear difference in the change in handgrip strength was found between calcium citrate and placebo.Time × group interaction p=0.80. | 2/4 LowPrecision of the estimate: No CI for the contrast is reported. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Secondary outcome, cramps assessed by questionnaire. | 11 trialRandomized Controlled Trial of Calcium Supplementation in Healthy, Nonosteoporotic, Older Men ↗ | 323 healthy men aged 40 and over without osteoporosis, 107 on placebo, 108 in each calcium group | - Randomized Controlled Trial of Calcium Supplementation in Healthy, Nonosteoporotic, Older Men ↗
|
|---|
| Complete absence of leg cramps in pregnant women | In a small open-label trial, pregnant women receiving calcium reported complete absence of leg cramps more often than women receiving no treatment. Certainty in this result is very low.RR 8.59 (95% CI 1.19–62.07); no cramps in 9 of 22 versus 1 of 21. | 1/4 Very lowPrecision of the estimate: 43 participants and an extremely wide interval. Consistency of results: One trial for this outcome; consistency cannot be determined. Applicability to the specified group: Pregnant women with cramps; do not extrapolate to other groups. Possible publication bias: Publication bias cannot be established from one study. Study methods: Open-label design and subjective outcome, randomization method unclear. | 11 trial in the reviewInterventions for leg cramps in pregnancy ↗ | 43 pregnant women with leg cramps at least twice weekly; 9/22 versus 1/21 without cramps after treatment | - Interventions for leg cramps in pregnancy ↗
|
|---|
| Frequency of leg cramps in pregnant women | In a small study of pregnant women, leg cramps were slightly less frequent with calcium carbonate than with placebo.-0.53 units on the original scale (95% CI -0.72…-0.34) | 2/4 LowPrecision of the estimate: One small study; limited reproducibility and information about the scale. Consistency of results: One trial for this outcome; consistency cannot be determined. Applicability to the specified group: Pregnant women with cramps; do not extrapolate to other groups. Possible publication bias: Publication bias cannot be established from one study. Study methods: Details available through the registry and review extraction; limited verification of conduct and a subjective outcome. | 11 trial in the reviewInterventions for leg cramps in pregnancy ↗ | 60 pregnant women in the third trimester with leg cramps | - Interventions for leg cramps in pregnancy ↗
|
|---|
| Intensity of leg cramps in pregnant women | In a small study of pregnant women, no clear difference in leg cramp intensity was found between calcium carbonate and placebo.-6.06 units on the original scale (95% CI -18.93…6.81) | 1/4 Very lowPrecision of the estimate: One small study, with an interval allowing opposite effects. Consistency of results: One trial for this outcome; consistency cannot be determined. Applicability to the specified group: Pregnant women with cramps; do not extrapolate to other groups. Possible publication bias: Publication bias cannot be established from one study. Study methods: Details available through the registry and review extraction; limited verification of conduct and a subjective outcome. | 11 trial in the reviewInterventions for leg cramps in pregnancy ↗ | 60 pregnant women in the third trimester with leg cramps | - Interventions for leg cramps in pregnancy ↗
|
|---|
| Maximum squat strength in women who train | In one study, the gain in maximum squat strength was 5.62 kg greater with amorphous calcium carbonate than with placebo. Analysis of strength changes over time between groups did not confirm a consistent difference.Squat 1RM gain: between-group difference +5.62 kg (95% CI +0.27…+10.96), p=0.049; group × time interaction p=0.421. | 1/4 Very lowPrecision of the estimate: 31 participants, no precise interval for the interaction. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Several dependent outcomes and methods of analysis. | 11 trialThe Effects of Amorphous Calcium Carbonate (ACC) Supplementation on Resistance Exercise Performance in Women ↗ | 31 women doing resistance training | - The Effects of Amorphous Calcium Carbonate (ACC) Supplementation on Resistance Exercise Performance in Women ↗
|
|---|
| Maximum bench press strength in women who train | In one study of women who trained, no clear advantage of amorphous calcium carbonate over placebo was found for bench press strength.Bench press 1RM gain: between-group difference +1.57 kg (95% CI −2.29…+5.43), p=0.432; group × time interaction p=0.738. | 1/4 Very lowPrecision of the estimate: 31 participants, no precise interval for the interaction. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Several dependent outcomes and methods of analysis. | 11 trialThe Effects of Amorphous Calcium Carbonate (ACC) Supplementation on Resistance Exercise Performance in Women ↗ | 31 women doing resistance training | - The Effects of Amorphous Calcium Carbonate (ACC) Supplementation on Resistance Exercise Performance in Women ↗
|
|---|
| Systolic blood pressure with initially normal blood pressure | In people with normal blood pressure, increased calcium intake was associated with a small average reduction in systolic blood pressure compared with control.Mean difference −1.37 mmHg (95% CI −2.08…−0.66). | 3/4 ModeratePrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed. | 1818 trials in the reviewCalcium supplementation for prevention of primary hypertension ↗ | people with normal blood pressure, 18 RCTs, 3140 participants | - Calcium supplementation for prevention of primary hypertension ↗
|
|---|
| Diastolic blood pressure with initially normal blood pressure | In people with normal blood pressure, increased calcium intake was associated with a small average reduction in diastolic blood pressure, about 1.5 mmHg, compared with control.Main analysis: −1.45 mmHg (95% CI −2.23…−0.67), I²=45%. Supplements only: −1.45 mmHg (95% CI −2.27…−0.63), 3001 participants. | 3/4 ModeratePrecision of the estimate: No separate downgrade is required for the stated wording. Consistency of results: Moderate heterogeneity; effects varied by age and regimen. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: No separate downgrade is required for the specified contrast. | 1717 trials in the reviewCalcium supplementation for prevention of primary hypertension ↗ | 3039 normotensive participants, 17 RCTs | - Calcium supplementation for prevention of primary hypertension ↗
|
|---|
| Total body weight with overweight or obesity | Calcium supplements showed no clear change in total body weight in people with overweight or obesity compared with placebo or a lower calcium dose.Mean difference −0.15 kg (95% CI −0.55…+0.24). | 2/4 LowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed. | 1717 trials in the reviewCalcium supplementation for people with overweight or obesity ↗ | 1317 participants with overweight or obesity, 17 RCTs | - Calcium supplementation for people with overweight or obesity ↗
|
|---|
| Body mass index with overweight or obesity | The average reduction in body mass index with calcium compared with placebo or a lower calcium dose was small, about 0.18 kg/m².−0.18 kg/m² (95% CI −0.22…−0.13), I²=0%. | 3/4 ModeratePrecision of the estimate: No separate downgrade is required for the stated wording. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Quality limitations in the original RCTs. | 99 trials in the reviewCalcium supplementation for people with overweight or obesity ↗ | People with overweight or obesity, 731 in 9 RCTs | - Calcium supplementation for people with overweight or obesity ↗
|
|---|
| Waist circumference with overweight or obesity | The average reduction in waist circumference with calcium compared with placebo or a lower calcium dose was small, about 0.51 cm.−0.51 cm (95% CI −0.72…−0.29), I²=0%. | 3/4 ModeratePrecision of the estimate: No separate downgrade is required for the stated wording. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Quality limitations in the original RCTs. | 66 trials in the reviewCalcium supplementation for people with overweight or obesity ↗ | People with overweight or obesity, 273 in 6 RCTs | - Calcium supplementation for people with overweight or obesity ↗
|
|---|
| Fat mass with overweight or obesity | The estimate of fat mass change allowed both a small decrease and a small increase with calcium compared with placebo or a lower calcium dose.Mean difference −0.34 kg (95% CI −0.73…+0.05); I²=97%. | 1/4 Very lowPrecision of the estimate: The CI crosses zero. Consistency of results: I²=97%. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Quality limitations in the original RCTs. | 1212 trials in the reviewCalcium supplementation for people with overweight or obesity ↗ | People with overweight or obesity, 812 in 12 RCTs | - Calcium supplementation for people with overweight or obesity ↗
|
|---|
| Tooth loss in older adults: calcium with vitamin D | In an additional analysis of older participants who completed a three-year study, loss of at least one tooth was reported less often with calcium and vitamin D than with placebo.Loss of at least one tooth: 11 of 82 versus 17 of 63; adjusted odds ratio 0.4 (95% CI 0.2–0.9). | 1/4 Very lowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed. | 11 trialCalcium and vitamin D supplements reduce tooth loss in the elderly ↗ | 145 older completers with available dental data | - Calcium and vitamin D supplements reduce tooth loss in the elderly ↗
|
|---|
| Tooth loss in men: calcium alone | Over two years in a study of healthy men aged 40 and over, two people each lost one tooth: one on placebo and one on 600 mg of calcium. This is too little to determine the effect of calcium on tooth loss.One event on placebo, one on 600 mg, none on 1200 mg. | 1/4 Very lowPrecision of the estimate: Only two events. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Secondary outcome, detection method not the primary one. | 11 trialRandomized Controlled Trial of Calcium Supplementation in Healthy, Nonosteoporotic, Older Men ↗ | 323 healthy men aged 40 and over without osteoporosis, 107 on placebo, 108 in each calcium group | - Randomized Controlled Trial of Calcium Supplementation in Healthy, Nonosteoporotic, Older Men ↗
|
|---|
| Lumbar spine and forearm bone density in breastfeeding women | A review of breastfeeding women found no clear overall difference in lumbar spine and forearm bone density between calcium and control.Lumbar spine: mean difference +0.74% (95% CI −0.10…+1.59); forearm: +0.53% (95% CI −0.35…+1.42). | 1/4 Very lowPrecision of the estimate: A small sample or confidence interval allows different effects. Consistency of results: Differences in interventions and populations are reflected in the limits of the conclusion; evidence is insufficient for a separate quantitative downgrade. Applicability to the specified group: Limited to the named group, composition, outcome, and dose; do not extrapolate to other regimens. Possible publication bias: Cannot be excluded; a reliable outcome-specific assessment has not been established. Study methods: The original trials have limitations or incomplete assessment; a full RoB 2 assessment for this outcome was not independently completed. | 11 review: lumbar spine — 5 RCTs, 527 women; forearm — 4 RCTs, 415 womenCalcium supplementation for improving bone density in lactating women: a systematic review and meta-analysis of randomized controlled trials ↗ | Breastfeeding women: 5 RCTs/567 in the review; lumbar spine BMD: 5 RCTs/527, forearm: 4 RCTs/415 | - Calcium supplementation for improving bone density in lactating women: a systematic review and meta-analysis of randomized controlled trials ↗
|
|---|
| Total hip bone density after childbirth | In one study, total hip bone density increased more with calcium than without supplementation between three and 12 months after childbirth, mainly after breastfeeding had ended. Fractures were not assessed by this measure.Bone density change: +6.44% versus +3.14%; difference +3.30 percentage points (95% CI +1.53…+5.07). | 1/4 Very lowPrecision of the estimate: One experiment and limited size. Consistency of results: No significant between-study inconsistency affecting the conclusion was established, or the estimate comes from one study. Applicability to the specified group: The conclusion is limited to the outcome and population directly studied. Possible publication bias: No grounds for a separate downgrade. Study methods: Open-label control, high risk of bias, allocation and reasons for missing data not confirmed. | 11 trial in the reviewEffect of calcium supplementation on the regain of BMD in Chinese lactating women with 4 major combined ER genotypes ↗ | 160 women from Wuhan were selected, 112 in the analysis according to Cai (58/54); baseline dietary intake 562 ± 197 mg of calcium/day | - Effect of calcium supplementation on the regain of BMD in Chinese lactating women with 4 major combined ER genotypes ↗
- Calcium supplementation for improving bone density in lactating women: a systematic review and meta-analysis of randomized controlled trials ↗
|
|---|